Healthcare provider profile · identity verified

Robert J Wendland, MD

Internal Medicine · TUALATIN, OR · NPI 1366593709

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	711	210
Losartan Potassium	Losartan Potassium	467	157
Amlodipine Besylate	Amlodipine Besylate	425	119
Lisinopril	Lisinopril	417	130
Levothyroxine Sodium	Levothyroxine Sodium	321	86
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	306	71
Simvastatin	Simvastatin	303	88
Rosuvastatin Calcium	Rosuvastatin Calcium	295	90
Trazodone Hcl	Trazodone Hcl	287	91
Oxycodone Hcl	Oxycodone Hcl	283	63
Metoprolol Tartrate	Metoprolol Tartrate	268	88
Metformin Hcl	Metformin Hcl	258	90
Albuterol Sulfate Hfa	Albuterol Sulfate	226	87
Gabapentin	Gabapentin	225	72
Tamsulosin Hcl	Tamsulosin Hcl	224	75
Pradaxa	Dabigatran Etexilate Mesylate	206	64
Pantoprazole Sodium	Pantoprazole Sodium	191	71
Atenolol	Atenolol	179	51
Finasteride	Finasteride	152	39
Metformin Hcl Er	Metformin Hcl	152	50
Hydrochlorothiazide	Hydrochlorothiazide	146	49
Duloxetine Hcl	Duloxetine Hcl	145	40
Sertraline Hcl	Sertraline Hcl	133	41
Terazosin Hcl	Terazosin Hcl	123	33
Prednisone	Prednisone	118	72
Donepezil Hcl	Donepezil Hcl	117	29
Bupropion Xl	Bupropion Hcl	116	42
Lorazepam	Lorazepam	110	32
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	110	32
Estradiol	Estradiol	108	44
Metoprolol Succinate	Metoprolol Succinate	108	43
Ipratropium Bromide	Ipratropium Bromide	105	47
Furosemide	Furosemide	102	37
Meloxicam	Meloxicam	102	40
Wixela Inhub	Fluticasone Propion/Salmeterol	102	38
Tramadol Hcl	Tramadol Hcl	100	25
Warfarin Sodium	Warfarin Sodium	97	28
Potassium Chloride	Potassium Chloride	94	30
Fluoxetine Hcl	Fluoxetine Hcl	90	27
Glipizide	Glipizide	89	31
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	87	24
Alendronate Sodium	Alendronate Sodium	86	34
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	85	26
Spironolactone	Spironolactone	85	30
Zolpidem Tartrate	Zolpidem Tartrate	85	20
Escitalopram Oxalate	Escitalopram Oxalate	83	22
Pravastatin Sodium	Pravastatin Sodium	82	27
Propranolol Hcl	Propranolol Hcl	80	21
Tizanidine Hcl	Tizanidine Hcl	79	25
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	76	23
Memantine Hcl	Memantine Hcl	76	17
Spiriva Respimat	Tiotropium Bromide	76	20
Acyclovir	Acyclovir	75	26
Alvesco	Ciclesonide	75	33
Jardiance	Empagliflozin	70	23
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	69	15
Ondansetron Odt	Ondansetron	66	24
Montelukast Sodium	Montelukast Sodium	63	23
Fluticasone Propionate	Fluticasone Propionate	60	17
Clopidogrel	Clopidogrel Bisulfate	57	18
Buspirone Hcl	Buspirone Hcl	56	13
Famotidine	Famotidine	56	18
Citalopram Hbr	Citalopram Hydrobromide	52	17
Mirtazapine	Mirtazapine	52	13
Ketoconazole	Ketoconazole	51	31
Allopurinol	Allopurinol	49	16
Diazepam	Diazepam	49	suppressed
Temazepam	Temazepam	48	suppressed
Omeprazole	Omeprazole	46	19
Bupropion Hcl Sr	Bupropion Hcl	45	18
Eliquis	Apixaban	45	suppressed
Pregabalin	Pregabalin	42	19
Cholestyramine	Cholestyramine (With Sugar)	40	13
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	40	18
Triamcinolone Acetonide	Triamcinolone Acetonide	40	28
Dicyclomine Hcl	Dicyclomine Hcl	38	13
Calcitonin-Salmon	Calcitonin,salmon,synthetic	37	suppressed
Valacyclovir	Valacyclovir Hcl	37	16
Eszopiclone	Eszopiclone	36	suppressed
Lamotrigine	Lamotrigine	36	suppressed
Lovastatin	Lovastatin	36	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	36	suppressed
Humulin N	Insulin Nph Human Isophane	35	13
Baclofen	Baclofen	34	suppressed
Xarelto	Rivaroxaban	34	suppressed
Alprazolam	Alprazolam	33	11
Hydrocortisone	Hydrocortisone	33	15
Primidone	Primidone	33	suppressed
Trospium Chloride	Trospium Chloride	33	12
Doxycycline Monohydrate	Doxycycline Monohydrate	32	24
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	32	suppressed
Torsemide	Torsemide	32	suppressed
Carvedilol	Carvedilol	31	11
Clonazepam	Clonazepam	30	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Sucralfate	Sucralfate	30	suppressed
Cefuroxime	Cefuroxime Axetil	28	23
Ezetimibe	Ezetimibe	27	suppressed
Fentanyl	Fentanyl	27	suppressed
Ozempic	Semaglutide	27	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	26	suppressed
Morphine Sulfate	Morphine Sulfate	26	suppressed
Levetiracetam	Levetiracetam	25	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	25	suppressed
Tenivac	Tetanus-Diphtheria Toxoids/Pf	25	25
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	24	suppressed
Methocarbamol	Methocarbamol	24	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	23	23
Clobetasol Propionate	Clobetasol Propionate	23	suppressed
Celecoxib	Celecoxib	22	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Morphine Sulfate Er	Morphine Sulfate	21	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	20	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	20	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	19	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	19	19
Epinephrine	Epinephrine	19	13
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Topiramate	Topiramate	18	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	17	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Metronidazole	Metronidazole	17	suppressed
Mupirocin	Mupirocin	17	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	15
Nitroglycerin	Nitroglycerin	17	14
Azelastine Hcl	Azelastine Hcl	16	11
Cefadroxil	Cefadroxil	16	15
Colchicine	Colchicine	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	suppressed
Testosterone	Testosterone	16	suppressed
Cartia Xt	Diltiazem Hcl	15	suppressed
Entresto	Sacubitril/Valsartan	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	15	15
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	14	suppressed
Cephalexin	Cephalexin	14	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	14	suppressed
Rizatriptan	Rizatriptan Benzoate	14	suppressed
Breyna	Budesonide/Formoterol Fumarate	13	suppressed
Clotrimazole	Clotrimazole	13	suppressed
Humulin R	Insulin Regular, Human	13	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Digoxin	Digoxin	12	suppressed
Dotti	Estradiol	12	suppressed
Emgality Pen	Galcanezumab-Gnlm	12	suppressed
Fluoridex	Fluoride (Sodium)	12	suppressed
Naloxone Hcl	Naloxone Hcl	12	12
Nifedipine Er	Nifedipine	12	suppressed
Oxazepam	Oxazepam	12	suppressed
Terbinafine Hcl	Terbinafine Hcl	12	suppressed
Ursodiol	Ursodiol	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Eplerenone	Eplerenone	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Retin-A	Tretinoin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error